TrialsgrambetaRCTs are beautiful

Evolut Low Risk

2019

Transcatheter Aortic-Valve Replacement with a Self-Expanding Valve in Low-Risk Patients

In 1,468 patients with severe AS at low surgical risk, TAVR with a self-expanding valve was non-inferior to surgical aortic-valve replacement for death or disabling stroke at 2 years.

Result

Death or disabling stroke at 24 months
Absolute difference
1.4 points

The absolute difference is derived from the event rates.

Also reported: (non-inferior); benefit persists at 4 years.

Original publication
Subtopic
TAVR
Design
RCT, non-inferiority
Relevance
Important: one of several pillars.
Source
Popma JJ, et al. N Engl J Med. 2019;380(18):1706-1715.doi 10.1056/NEJMoa1816885

Discussion & critique

With PARTNER 3, extended TAVR to low-risk patients. Self-expanding valves bring more pacemakers; long-term durability data are still maturing.

Discussed in podcasts